Hyderabad’s Biological E: The dark horse in India’s vaccine race
Biological E has forged multiple deals to co-develop and manufacture Covid-19 vaccines, and is prepared to take on the biggest in the business. It could...
Continue ReadingBiological E has forged multiple deals to co-develop and manufacture Covid-19 vaccines, and is prepared to take on the biggest in the business. It could...
Continue ReadingEarlier, Aurobindo Pharma Managing Director N Govindarajan had said that proceeds from Natrol’s divestiture will be used to reduce debt and other new strategic initiatives....
Continue ReadingHyderabad-based biologicals company, Indian Immunologicals Ltd (IIL), announced the ground-breaking of a new viral antigen manufacturing facility in Phase III of Genome Valley, Karkapatla, Ranga...
Continue ReadingAccording to official sources based in Delhi and Ahmedabad, Luxembourg firm B Medical Systems is sending a high-level team to Gujarat next week to set...
Continue ReadingClick Here to Register
Continue ReadingSingapore’s Breathonix has said a clinical trial of its COVID-19 breathalyzer test was able to achieve at least 90% accuracy after screening participants on-site for...
Continue ReadingSrivastava will head Legacy Healthcare’s India operations and lead the company’s initiatives from the India office in Bengaluru, with a focus on research to explore...
Continue ReadingTelangana is aiming to achieve $50 billion in cluster revenues (and $100 billion ecosystem valuation) by 2030, and believes that the sector would need to...
Continue ReadingMerck & Co’s CEO Kenneth Frazier has warned that the drugs and vaccines in the pipeline to combat COVID-19 may not be enough to swiftly...
Continue Reading